awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34629803-4D6F8BEF-9830-4C28-8EB9-37CF6E0B1CC8
Q34629803-4D6F8BEF-9830-4C28-8EB9-37CF6E0B1CC8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34629803-4D6F8BEF-9830-4C28-8EB9-37CF6E0B1CC8
A phase I clinical-pharmacodynamic study of the farnesyltransferase inhibitor tipifarnib in combination with the proteasome inhibitor bortezomib in advanced acute leukemias
P2860
Q34629803-4D6F8BEF-9830-4C28-8EB9-37CF6E0B1CC8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34629803-4D6F8BEF-9830-4C28-8EB9-37CF6E0B1CC8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
65322c5f28cf3d6d9430420e714a1856c42fb775
P2860
The proteasome as a target for cancer therapy.